Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 2, 2006, Pages 245-246

  Schildgen, Oliver ^a   Hartmann, Heinz ^b   Gerlich, Wolfram H ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; LAMIVUDINE; PEGINTERFERON; TENOFOVIR;

DNA POLYMORPHISM; DRUG METABOLISM; DRUG SUBSTITUTION; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; VIREMIA; VIRUS REACTIVATION; VIRUS REPLICATION;

ADENINE; ANTIVIRAL AGENTS; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; RECURRENCE; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 32644478412     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500319013     Document Type: Letter

References (9)

1. van Bömmel T, Berg T. Reactivation of viral replication in three patients with lamivudine-resistant hepatitis B after replacement of tenofovir by adefovir. Hepatology 2005;42:239-40.
2. Schildgen O, Schewe CK, Vogel M, Daumer M, Kaiser R, Weitner L, et al. Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment AIDS 2004;18:2325-7.
3. Schildgen O, Wend UC, Hartmann H, Helm M, Rockstroh JK, Will H, et al. Variant of hepatitis B virus primarily resistant to adefovir, but sensitive to tenofovir. submitted, in revision
4. van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, Schurmann D, et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection Hepatology 2004;40:1421-5.
5. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Adefovir dipivoxil for the treatment of hepatitis B in antigen-negative chronic hepatitis B. N Engl J Med 2003;348:800-7.
6. Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 2000;32:129-34.
7. Peters MG, Hann HH, Martin P, Heathcote EJ, Buggisch P, Rubin R, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2004;126:91-101.
8. Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003;125:292-7.
9. Yang H, Westland C, Delaney W IV, Angus PW, Locarnini SA, Kitis G, et al. Complete genotypic and phenotypic analyses of HBV mutations identified in HBeAg-negative chronic hepatitis B patients receiving 96 weeks of adefovir dipivoxil (ADV) [abstract]. Hepatology 2003;38:705A.